معرفی
Morten Baltzer Houlind is a Guest Researcher in the Department of Drug Design and Pharmacology at the University of Copenhagen, specializing in translational and clinical pharmacology. His work focuses on optimizing drug therapy for elderly patients through advanced renal function assessment and biomarker development.
Dr. Houlind's research centers on geriatric pharmacology with emphasis on glomerular filtration rate (GFR) measurement techniques, biomarker validation (suPAR, NGAL, KIM-1, GDF-15), and cannabinoid pharmacokinetics in aging populations. His projects include developing dried blood spot testing protocols, improving medication review systems for acute hospital admissions, and conducting clinical trials on appetite stimulation therapies for elderly patients with poor appetite.
Analysis of his recent publications reveals a cohesive research trajectory focused on precision dosing in geriatric care, integrating pharmacokinetic modeling with novel biomarker discovery to address renal impairment challenges. His work consistently targets practical clinical applications for vulnerable elderly populations, particularly in hospital settings where polypharmacy and renal dysfunction complicate treatment.
